Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Randomized Controlled Trial

Research Support, Non-U.S. Gov't

Multicenter Study

Clinical Trial, Phase II

Clinical Trial, Phase III

Clinical Trial

Comparative Study

Review

Meta-Analysis

Systematic Review

Clinical Trial, Phase I

Research Support, N.I.H., Extramural

Observational Study

Case Reports

Research Support, U.S. Gov't, Non-P.H.S.

Letter

Clinical Trial, Phase IV

Clinical Trial Protocol

Publication Year

From

Quick links

Individual year

2026

2025

2024

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Hand-Foot Syndrome""[mesh_terms]

75 Results

Searching titles within these results

Sorafenib-associated hand-foot skin reaction: practical advice on diagnosis, mechanism, prevention, and management.

Leilei Ai, Ziheng Xu, Bo Yang, Qiaojun He, Peihua Luo

Expert review of clinical pharmacology 2019;12(12):1121-1127

Full Text

Abstract

Randomized double-blind, placebo-controlled study of topical diclofenac in the prevention of hand-foot syndrome in patients receiving capecitabine (the D-TORCH study).

Akhil Santhosh, Atul Batra, Atul Sharma, Ravindra Mohan Pandey, Winson Y Cheung, Nishkarsh Gupta, Ishaan Gupta, Chandra Prakash Prasad, Ajay Gogia, Raja Pramanik, Akash Kumar

Trials 2022;23(1):420

Free Full Text

Abstract

Pyridoxine Is Effective for Preventing Hand-Foot Syndrome Induced by Pegylated Liposomal Doxorubicin for Multiple Myeloma: The Results of a Randomized Study.

Li Juan, Kuang Lifen, Gu Jingli, Liu Junru, Li Xiaozhe, Chen Meilan, Huang Beihui

Integrative cancer therapies 2022;21():15347354221140402

Free Full Text

Abstract

Folate-Associated DNA Methylation and Chemotherapy-Induced Toxicities in Patients With Colorectal Cancer.

Sajini N H Ariyaratne, Dieuwertje E Kok, Jill A McKay, Nienke R K Zwart

Molecular nutrition & food research 2025;69(14):e70127

Free Full Text

Abstract

Effect of a Novel Soaking Solution Used in Patients With Hand-Foot Syndrome as a Result of Capecitabine Treatment: A Randomized and Self-Controlled Trial.

Jing Cheng, Xin Peng, Haiyan Chang, Jue Wang, Renwang Chen, Ting Hu, Qiong Wang, Yuxiu Xie

Clinical breast cancer 2022;22(5):e685-e690

Full Text

Abstract

Prophylactic strategies for hand-foot syndrome/skin reaction associated with systemic cancer treatment: a meta-analysis of randomized controlled trials.

Paula Isabel G Franco, Rubi K Li, Jessa Gilda P Pandy

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2022;30(11):8655-8666

Full Text

Abstract

Topical henna and curcumin (Alpha®) ointment efficacy for prevention of capecitabine induced hand-foot syndrome: A randomized, triple-blinded, placebo-controlled clinical.

Sare Hosseini, Ali Taghizadeh-Kermani, Sara Rasta, Sepideh Elyasi

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 2022;30(1):117-125

Free Full Text

Abstract

A clinical scoring tool validated with machine learning for predicting severe hand-foot syndrome from sorafenib in hepatocellular carcinoma.

Ahmad Y Abuhelwa, Ashley M Hopkins, Anniepreet Tuteja, Kiran Shankaran, Warit Ruanglertboon, Ross A McKinnon, Hoi-Yee Yuen, Sarah Badaoui, Michael J Sorich

Cancer chemotherapy and pharmacology 2022;89(4):479-485

Free Full Text

Abstract

A randomized phase II study evaluating pyridoxine for the prevention of hand-foot syndrome associated with capecitabine therapy for advanced or metastatic breast cancer.

Tatsuya Toyama, Akiyo Yoshimura, Takako Hayashi, Naomi Kobayashi, Kanako Saito, Michiko Tsuneizumi, Masataka Sawaki, Masaya Hattori, Takumi Nakada, Isao Yokota, Hiroji Iwata

Breast cancer (Tokyo, Japan) 2019;25(6):729-735

Full Text

Abstract

Topical henna ameliorated capecitabine-induced hand-foot syndrome.

Saher Ilyas, Komal Wasif, Muhammad Wasif Saif

Cutaneous and ocular toxicology 2015;33(3):253-5

Full Text

Abstract

Clinical presentation and management of hand-foot skin reaction associated with sorafenib in combination with cytotoxic chemotherapy: experience in breast cancer.

Patricia Gomez, Mario E Lacouture

The oncologist 2012;16(11):1508-19

Free Full Text

Abstract

Validation of the prophylactic efficacy of urea-based creams on sorafenib-induced hand-foot skin reaction in patients with advanced hepatocellular carcinoma: A randomised experiment study.

Shu-Fen Lu, Ling-Chun Lu, Sophia H Hu, Shang-Laing Wu, Heng-Hsin Tung, Ru-Yu Lien

Cancer reports (Hoboken, N.J.) 2022;5(7):e1532

Free Full Text

Abstract

Topical Silymarin Administration for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.

Sepideh Elyasi, Farzaneh Sadat Rezazadeh Shojaee, Abolghasem Allahyari, Gholamreza Karimi

Phytotherapy research : PTR 2017;31(9):1323-1329

Full Text

Abstract

Effect of modified taohongsiwu decoction on patients with chemotherapy-induced hand-foot syndrome.

Changlin Zhao, Jia Chen, Bin Yu, Xianlin Wu, Congqi Dai, Chang Zhou, Xiaoyin Chen

Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan 2014;34(1):10-4

Free Full Text

Abstract

Influence of Chemotherapy on the Antioxidant Status of Human Skin.

Bich Na Lee, Sora Jung, Maxim E Darvin, Jan Eucker, Dagmar Kühnhardt, Jalid Sehouli, Radoslav Chekerov, Alexa Patzelt, Harald Fuss, Ruo-Xi Yu, Jürgen Lademann

Anticancer research 2017;36(8):4089-93

Full Text

Abstract

Results: 1 – 15 / 75

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Hand-Foot Syndrome""[mesh_terms]

Sorafenib-associated hand-foot skin reaction: practical advice on diagnosis, mechanism, prevention, and management.

Randomized double-blind, placebo-controlled study of topical diclofenac in the prevention of hand-foot syndrome in patients receiving capecitabine (the D-TORCH study).

Pyridoxine Is Effective for Preventing Hand-Foot Syndrome Induced by Pegylated Liposomal Doxorubicin for Multiple Myeloma: The Results of a Randomized Study.

Folate-Associated DNA Methylation and Chemotherapy-Induced Toxicities in Patients With Colorectal Cancer.

Effect of a Novel Soaking Solution Used in Patients With Hand-Foot Syndrome as a Result of Capecitabine Treatment: A Randomized and Self-Controlled Trial.

Prophylactic strategies for hand-foot syndrome/skin reaction associated with systemic cancer treatment: a meta-analysis of randomized controlled trials.

Topical henna and curcumin (Alpha®) ointment efficacy for prevention of capecitabine induced hand-foot syndrome: A randomized, triple-blinded, placebo-controlled clinical.

A clinical scoring tool validated with machine learning for predicting severe hand-foot syndrome from sorafenib in hepatocellular carcinoma.

A randomized phase II study evaluating pyridoxine for the prevention of hand-foot syndrome associated with capecitabine therapy for advanced or metastatic breast cancer.

Topical henna ameliorated capecitabine-induced hand-foot syndrome.

Clinical presentation and management of hand-foot skin reaction associated with sorafenib in combination with cytotoxic chemotherapy: experience in breast cancer.

Validation of the prophylactic efficacy of urea-based creams on sorafenib-induced hand-foot skin reaction in patients with advanced hepatocellular carcinoma: A randomised experiment study.

Topical Silymarin Administration for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.

Effect of modified taohongsiwu decoction on patients with chemotherapy-induced hand-foot syndrome.

Influence of Chemotherapy on the Antioxidant Status of Human Skin.

Results for
""Hand-Foot Syndrome""[mesh_terms]